Clinical Trials Directory

Trials / Terminated

TerminatedNCT02173613

Reduction the Duration of Antibiotic Therapy in the Elderly (PROPAGE)

Reduction of the Duration of Antibiotic Guided by Procalcitonin in Infections Lungs of Hospitalized Elderly: a Randomized

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
117 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
80 Years
Healthy volunteers
Not accepted

Summary

The main objective is to evaluate the interest of the repeated measurement of procalcitonin in patients with pulmonary infection to reduce the duration of antibiotic therapy in comparison with a conventional clinical strategy.

Conditions

Interventions

TypeNameDescription
OTHERprocalcitonineThe recommendations will be based on the level of PCT: 4 levels of advice will be given: * It is highly recommended to stop antibiotics if PCT \<0.1ng/ml, and the recommended stop if 0.1ng/ml \<PCT \<0.25 ng / ml. * It is recommended to continue treatment if 0.25 ng / ml \<PCT ng / ml. * Finally, if the initial PCT greater than 10 ng / ml, a stop will be advised in case of reduction to less than 10% of baseline level.

Timeline

Start date
2012-08-01
Primary completion
2015-12-01
Completion
2016-03-01
First posted
2014-06-25
Last updated
2022-05-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02173613. Inclusion in this directory is not an endorsement.